United Capital Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.93M Sell
2,100
-200
-9% -$203K 0.01% 559
2025
Q4
$2.47M Buy
2,300
+1,400
+156% +$1.34M 0.01% 484
2025
Q3
$687K Sell
900
-300
-25% -$223K ﹤0.01% 763
2025
Q2
$935K Buy
1,200
+100
+9% +$77.7K 0.01% 607
2025
Q1
$909K Buy
1,100
+600
+120% +$499K 0.01% 589
2024
Q4
$386K Sell
500
-442,470
-100% -$366M ﹤0.01% 803
2024
Q3
$500 Buy
+442,970
New +$398M ﹤0.01% 1059

Other funds holding LLY

United Capital Financial Advisors's LLY Position: Q1 2026 in Review

United Capital Financial Advisors increased its Eli Lilly (LLY) stake by 0.44% in Q1 2026, buying an estimated $268K and bringing the position to 60,590 shares worth $55.7M. The position accounts for 0.34% of the portfolio, ranked #55.

United Capital Financial Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $64.8M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • United Capital Financial Advisors held 60,590 shares of Eli Lilly worth $55.7M as of Q1 2026.
  • United Capital Financial Advisors bought 264 Eli Lilly shares in Q1 2026, an estimated $268K.
  • Eli Lilly made up 0.34% of United Capital Financial Advisors's portfolio in Q1 2026, its #55 holding.
  • United Capital Financial Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • United Capital Financial Advisors's Eli Lilly position peaked at $64.8M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.